Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

VRNA

Verona Pharma Plc ADR

May 08 • 04:00PM ET

14.88

Dollar change +0.09
Percentage change 0.61	%

Healthcare • Biotechnology • United Kingdom • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Index	-	P/E	-	EPS (ttm)	-0.69	Insider Own	22.62%	Shs Outstand	80.44M	Perf Week	-2.23%
Market Cap	1.15B	Forward P/E	-	EPS next Y	-0.21	Insider Trans	0.70%	Shs Float	59.93M	Perf Month	-9.65%
Income	-54.59M	PEG	-	EPS next Q	-0.03	Inst Own	63.64%	Short Float	10.12%	Perf Quarter	-8.94%
Sales	0.00M	P/S	-	EPS this Y	-82.22%	Inst Trans	43.43%	Short Ratio	13.53	Perf Half Y	-1.59%
Book/sh	3.10	P/B	4.80	EPS next Y	-30.08%	ROA	-19.23%	Short Interest	6.07M	Perf Year	-31.96%
Cash/sh	3.51	P/C	4.24	EPS next 5Y	-	ROE	-22.76%	52W Range	11.83 - 23.81	Perf YTD	-25.15%
Dividend Est.	-	P/FCF	-	EPS past 5Y	19.36%	ROI	-18.23%	52W High	-37.51%	Beta	0.39
Dividend TTM	-	Quick Ratio	33.33	Sales past 5Y	-39.77%	Gross Margin	-110.38%	52W Low	25.78%	ATR (14)	0.60
Dividend Ex-Date	-	Current Ratio	33.33	EPS Y/Y TTM	35.45%	Oper. Margin	0.00%	RSI (14)	38.03	Volatility	4.13% 3.52%
Employees	79	Debt/Eq	0.21	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	1.00	Target Price	34.29
Option/Short	Yes / Yes	LT Debt/Eq	0.20	EPS Q/Q	-27.40%	Payout	-	Rel Volume	0.94	Prev Close	14.79
Sales Surprise	-	EPS Surprise	33.33%	Sales Q/Q	-100.00%	Earnings	May 09 BMO	Avg Volume	448.29K	Price	14.88
SMA20	-5.01%	SMA50	-7.75%	SMA200	-10.75%	Trades		Volume	422,783	Change	0.61%

Date	Action	Analyst	Rating Change	Price Target Change
May-22-23	Resumed	Jefferies	Buy	$35 → $38
Sep-19-22	Resumed	Wedbush	Outperform	$27
Aug-26-22	Initiated	Piper Sandler	Overweight	$31
Sep-13-21	Initiated	H.C. Wainwright	Buy	$25
Aug-25-20	Initiated	Jefferies	Buy	$17
Aug-10-20	Initiated	Canaccord Genuity	Buy	$17
Apr-18-19	Initiated	BTIG Research	Buy	$17

Today 01:22PM	Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-02-24 02:00AM	Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024 (GlobeNewswire)
Apr-25-24 02:00AM	Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update (GlobeNewswire)
Mar-04-24 02:00AM	Andrew Fisher Joins Verona Pharma as General Counsel (GlobeNewswire) -5.00%
Mar-01-24 09:03AM	Verona Pharma plc (NASDAQ:VRNA) Q4 2023 Earnings Call Transcript (Insider Monkey) +5.63%
08:45AM	Loading…
08:45AM	3 Healthcare Stocks That Have Outperformed Nvidia Since 2022 (Motley Fool)
Feb-29-24 06:36AM	Verona Pharma PLC Reports Fourth Quarter and Full Year 2023 Financial Results (GuruFocus.com)
02:00AM	Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Feb-15-24 02:00AM	Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update (GlobeNewswire)
Feb-01-24 02:00AM	Michael Austwick Joins Verona Pharma as Non-Executive Director (GlobeNewswire)
Jan-03-24 02:00AM	Verona Pharma to Present at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-02-24 02:00AM	Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital (GlobeNewswire) -5.38%
Dec-30-23 06:50AM	3 Stocks That Could Be Monster Winners in 2024 (Motley Fool)
Nov-23-23 09:55AM	Wall Street Analysts Believe Verona Pharma PLC American Depositary Share (VRNA) Could Rally 135.87%: Here's is How to Trade (Zacks)
Nov-17-23 02:00AM	Verona Pharma's President and CEO David Zaccardelli Wins Executive of the Year SCRIP Award (GlobeNewswire) +6.28%
09:09AM	Loading…
Nov-14-23 09:09AM	11 Best Undervalued UK Stocks To Buy Now (Insider Monkey) +5.62%
Nov-08-23 02:00AM	Verona Pharma Announces November 2023 Investor Conference Participation (GlobeNewswire)
Nov-07-23 09:55AM	Does Verona Pharma PLC American Depositary Share (VRNA) Have the Potential to Rally 119.18% as Wall Street Analysts Expect? (Zacks)
Nov-05-23 10:33AM	Verona Pharma plc (NASDAQ:VRNA) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-04-23 05:02AM	Insider Sell: Chief Medical Officer Kathleen Rickard Sells 58,752 Shares of Verona Pharma PLC (GuruFocus.com)
Nov-02-23 08:03AM	Verona Pharma PLC (VRNA) Reports Q3 2023 Financial Results and Corporate Update (GuruFocus.com)
03:04AM	Verona Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Oct-23-23 04:57AM	Analysts Say These 3 Stocks Are Their Top Picks for 2024 (TipRanks)
Oct-19-23 02:00AM	Verona Pharma to Report Third Quarter 2023 Financial Results and Provide Corporate Update (GlobeNewswire)
Oct-11-23 09:55AM	Verona Pharma PLC American Depositary Share (VRNA) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? (Zacks)
Oct-06-23 02:00AM	Verona Pharma to Host Investor Update on Commercialization Preparation for Ensifentrine on October 18, 2023 (GlobeNewswire)
Oct-04-23 09:35AM	Down -21.27% in 4 Weeks, Here's Why Verona Pharma PLC American Depositary Share (VRNA) Looks Ripe for a Turnaround (Zacks)
Oct-03-23 02:00AM	Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at CHEST 2023 (GlobeNewswire)
Sep-26-23 12:17PM	Raleigh pharma preps for hiring spree, expands office footprint with sublease (American City Business Journals)
Sep-11-23 02:00AM	Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPD (GlobeNewswire)
02:00AM	Loading…
Sep-06-23 02:00AM	Verona Pharma to Present Additional Analysis of Phase 3 ENHANCE-1 Study in COPD at ERS International Congress 2023 (GlobeNewswire)
Aug-31-23 10:16PM	12 Best High Risk High Reward Stocks To Buy Now (Insider Monkey) +5.03%
02:00AM	Christina Ackermann Joins Verona Pharma as Non-Executive Director (GlobeNewswire)
Aug-08-23 07:42AM	Verona Pharma plc's (NASDAQ:VRNA) institutional investors lost 14% over the past week but have profited from longer-term gains (Simply Wall St.)
06:41AM	Verona Pharma plc (NASDAQ:VRNA) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-03-23 02:00AM	Verona Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Jul-26-23 02:00AM	Verona Pharma to Present at 43rd Annual Canaccord Growth Conference (GlobeNewswire)
Jul-20-23 02:00AM	Verona Pharma to Report Second Quarter 2023 Financial Results and Provide Corporate Update (GlobeNewswire)
Jun-28-23 02:00AM	Verona Pharma Announces Publication of Phase 3 ENHANCE Data in the American Journal of Respiratory and Critical Care Medicine (GlobeNewswire)
Jun-27-23 02:00AM	Verona Pharma Submits New Drug Application to US FDA for Ensifentrine for the Maintenance Treatment of COPD (GlobeNewswire)
May-24-23 02:00AM	Verona Pharma to Present at Jefferies Healthcare Conference (GlobeNewswire)
May-09-23 02:00AM	Verona Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
May-02-23 02:00AM	Verona Pharma to Present Expanded Analyses of Positive Phase 3 ENHANCE Studies in COPD in Multiple Presentations at ATS 2023 (GlobeNewswire)
Apr-25-23 02:00AM	Verona Pharma to Report First Quarter 2023 Financial Results and Provide Corporate Update (GlobeNewswire)
Apr-11-23 06:05AM	When Will Verona Pharma plc (NASDAQ:VRNA) Breakeven? (Simply Wall St.)
Apr-10-23 02:00AM	Nuance Pharma Announces Dosing of First Patient in ENHANCE China Phase 3 Trial for COPD (GlobeNewswire)
Apr-04-23 06:15PM	Verona Pharma PLC American Depositary Share (VRNA) Gains As Market Dips: What You Should Know (Zacks)
Mar-30-23 05:22PM	Top Healthcare Stocks for April 2023 (Investopedia)
Mar-28-23 06:15PM	Verona Pharma PLC American Depositary Share (VRNA) Dips More Than Broader Markets: What You Should Know (Zacks)
Mar-22-23 06:00PM	Verona Pharma PLC American Depositary Share (VRNA) Stock Moves -0.46%: What You Should Know (Zacks)
Mar-15-23 11:44AM	7 Biotech Stocks That Could Be the Next Big Thing (InvestorPlace)
Mar-14-23 06:15PM	Verona Pharma PLC American Depositary Share (VRNA) Stock Sinks As Market Gains: What You Should Know (Zacks)
Mar-09-23 01:59AM	Verona Pharma plc (NASDAQ:VRNA) Q4 2022 Earnings Call Transcript (Insider Monkey) -9.20%
Mar-08-23 02:50PM	Top Healthcare Stocks for March 2023 (Investopedia)
07:56AM	Raleigh drugmaker eyes regulatory push for COPD treatment (American City Business Journals)
Mar-07-23 02:00AM	Verona Pharma Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update (GlobeNewswire) -10.51%
Mar-01-23 06:00PM	Verona Pharma PLC American Depositary Share (VRNA) Gains As Market Dips: What You Should Know (Zacks)
05:57AM	Verona Pharma plc (NASDAQ:VRNA) is definitely on the radar of institutional investors who own 39% of the company (Simply Wall St.)
Feb-23-23 06:00PM	Verona Pharma PLC American Depositary Share (VRNA) Gains But Lags Market: What You Should Know (Zacks)
Feb-21-23 02:00AM	Verona Pharma to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update (GlobeNewswire)
Feb-15-23 11:49AM	Verona (VRNA) to Report Q4 Earnings: What's in the Cards? (Zacks)
Feb-14-23 06:00PM	Verona Pharma PLC American Depositary Share (VRNA) Gains As Market Dips: What You Should Know (Zacks)
Feb-08-23 06:00PM	Verona Pharma PLC American Depositary Share (VRNA) Dips More Than Broader Markets: What You Should Know (Zacks)
Feb-02-23 06:00PM	Verona Pharma PLC American Depositary Share (VRNA) Stock Sinks As Market Gains: What You Should Know (Zacks)
Jan-23-23 06:15PM	Verona Pharma PLC American Depositary Share (VRNA) Stock Sinks As Market Gains: What You Should Know (Zacks)
Jan-17-23 06:15PM	Verona Pharma PLC American Depositary Share (VRNA) Dips More Than Broader Markets: What You Should Know (Zacks)
Jan-10-23 06:15PM	Verona Pharma PLC American Depositary Share (VRNA) Stock Sinks As Market Gains: What You Should Know (Zacks)
Jan-03-23 05:40AM	The Zacks Analyst Blog Highlights AVEO Pharmaceuticals, Cabaletta Bio, Verona Pharma and Wave Life Sciences (Zacks) -6.31%
Jan-02-23 07:22AM	Why These 7 Healthcare Stocks Could Soar in 2023 (InvestorPlace)
Dec-30-22 06:25PM	American Equity and Avis Budget Stock See Action From Activist Investors (Barrons.com) +7.05%
09:03AM	4 Drug Stocks That More Than Doubled This Year (Zacks)
Dec-28-22 11:58PM	12 Best Performing NASDAQ Stocks in 2022 (Insider Monkey) -7.47%
Dec-22-22 08:50AM	Here's Why Momentum in Verona Pharma PLC American Depositary Share (VRNA) Should Keep going (Zacks)
06:00AM	7 Drug Stocks That Will Soar in 2023 (InvestorPlace)
Dec-20-22 04:06PM	Top-Notch Verona Pharma Scores A Win In COPD And Hits A Four-Year High (Investor's Business Daily) +37.81%
02:02PM	Raleigh drugmaker's stock jumps on positive results for lung disease treatment (American City Business Journals)
08:43AM	Verona Pharma Stock Garners Investors' Attention After Successful COPD Trial (Benzinga)
08:18AM	Verona Pharma's stock jumps 39% after sharing positive data for its COPD drug (MarketWatch)
08:14AM	Lucid Is Revving Up, but This Nasdaq Stock Is Jumping Even More (Motley Fool)
02:00AM	Verona Pharma Announces Ensifentrine Meets Primary and Key Secondary Endpoints in Phase 3 ENHANCE-1 Trial for COPD (GlobeNewswire)
Dec-19-22 04:01PM	Verona Pharma to Announce Top-line Data from Phase 3 ENHANCE-1 Trial of Nebulized Ensifentrine for COPD (GlobeNewswire)
Dec-06-22 08:50AM	Here's What Could Help Verona Pharma PLC American Depositary Share (VRNA) Maintain Its Recent Price Strength (Zacks)
Dec-05-22 12:00PM	Here's Why Verona Pharma PLC American Depositary Share (VRNA) is a Great Momentum Stock to Buy (Zacks)
Dec-02-22 09:55AM	Wall Street Analysts See a 95% Upside in Verona Pharma PLC American Depositary Share (VRNA): Can the Stock Really Move This High? (Zacks)
Nov-15-22 09:55AM	How Much Upside is Left in Verona Pharma PLC American Depositary Share (VRNA)? Wall Street Analysts Think 110% (Zacks)
08:50AM	Here's Why Momentum in Verona Pharma PLC American Depositary Share (VRNA) Should Keep going (Zacks)
Nov-09-22 02:00AM	Verona Pharma Reports Third Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-06-22 07:00PM	These 2022 Winning Stocks Can Keep Soaring in 2023, Say Analysts (TipRanks)
Nov-02-22 09:48AM	Verona Pharma (NASDAQ:VRNA) shareholder returns have been stellar, earning 194% in 3 years (Simply Wall St.)
03:00AM	Verona Pharma Announces November 2022 Investor Conference Participation (GlobeNewswire)
Oct-26-22 02:00AM	Verona Pharma to Report Third Quarter 2022 Financial Results and Provide Corporate Update (GlobeNewswire)
Oct-17-22 04:44PM	Raleigh pharma secures $150M to commercialize COPD treatment (American City Business Journals)
02:00AM	Verona Pharma Secures Debt Financing of up to $150 Million from Oxford Finance (GlobeNewswire)
Oct-14-22 02:00AM	Verona Pharma Announces Analyses Demonstrating Ensifentrine Reduced Exacerbation Rates Across Subgroups in Phase 3 ENHANCE-2 Trial for COPD (GlobeNewswire)
Sep-22-22 06:51AM	Individual investors who have a significant stake must be disappointed along with institutions after Verona Pharma plc's (NASDAQ:VRNA) market cap dropped by US$69m (Simply Wall St.) -6.02%
Sep-20-22 12:24PM	Here Are 10 Biotech Stocks That Would Have Netted You $12,000 This Year (Investor's Business Daily)
Aug-29-22 02:48PM	HC Wainwright Raises Price For This Lung Disease Stock On First Pivotal Readout (Benzinga)
02:00AM	Verona Pharma to Present at H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-24-22 02:00AM	Verona Pharma strengthens commercialization leadership team (GlobeNewswire)
Aug-19-22 02:46AM	Nuance Pharma receives Clearance to begin Pivotal Clinical Trials with Ensifentrine for COPD in China (GlobeNewswire) -6.40%

Verona Pharma Plc engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. It focuses on developing inhaled ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease. The company was founded by Michael J. A. Walker and Clive P. Page on February 24, 2005 and is headquartered in London, the United Kingdom.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rickard Kathleen A.	Chief Medical Officer	May 03 '24	Sale	1.96	36,248	71,032	2,621,552	May 03 07:21 PM
Rickard Kathleen A.	Chief Medical Officer	Feb 05 '24	Sale	2.22	36,248	80,503	2,731,624	Feb 05 06:11 PM
Edwards Martin	Director	Nov 20 '23	Buy	1.84	33,736	61,973	144,800	Nov 22 05:09 PM
EBSWORTH DAVID R	Director	Nov 06 '23	Buy	1.98	160,000	316,080	844,643	Nov 08 04:15 PM
Rickard Kathleen A.	Chief Medical Officer	Nov 03 '23	Sale	1.92	58,752	112,804	2,840,640	Nov 03 08:11 PM
Hahn Mark W	Chief Financial Officer	Aug 07 '23	Sale	2.47	8,616	21,263	15,521,248	Aug 07 09:17 PM
ZACCARDELLI DAVID	President and CEO	Aug 07 '23	Sale	2.47	8,616	21,263	16,431,800	Aug 07 09:17 PM
Rickard Kathleen A.	Chief Medical Officer	Aug 07 '23	Sale	2.47	1,600	3,949	2,872,528	Aug 07 09:19 PM
Poll Claire	General Counsel	Aug 07 '23	Sale	2.47	1,512	3,731	1,907,367	Aug 07 09:15 PM
ZACCARDELLI DAVID	President and CEO	Aug 04 '23	Sale	2.50	150,000	374,880	16,440,416	Aug 07 09:17 PM
Hahn Mark W	Chief Financial Officer	Aug 04 '23	Sale	2.50	150,000	374,880	15,529,864	Aug 07 09:17 PM
Rickard Kathleen A.	Chief Medical Officer	Aug 04 '23	Sale	2.50	27,944	69,838	2,874,128	Aug 07 09:19 PM
Poll Claire	General Counsel	Aug 04 '23	Sale	2.50	26,352	65,859	1,908,879	Aug 07 09:15 PM
Hahn Mark W	Chief Financial Officer	Aug 03 '23	Sale	2.54	117,272	297,754	15,679,864	Aug 07 09:17 PM
ZACCARDELLI DAVID	President and CEO	Aug 03 '23	Sale	2.54	117,272	297,754	16,590,416	Aug 07 09:17 PM
Rickard Kathleen A.	Chief Medical Officer	Aug 03 '23	Sale	2.55	50,600	128,790	2,902,072	Aug 07 09:19 PM
Poll Claire	General Counsel	Aug 03 '23	Sale	2.54	20,608	52,324	1,935,231	Aug 07 09:15 PM
ZACCARDELLI DAVID	President and CEO	Aug 02 '23	Sale	2.59	73,704	191,114	16,707,688	Aug 03 08:29 PM
Hahn Mark W	Chief Financial Officer	Aug 02 '23	Sale	2.59	73,704	191,114	15,797,136	Aug 03 08:31 PM
Rickard Kathleen A.	Chief Medical Officer	Aug 02 '23	Sale	2.59	13,728	35,597	2,952,672	Aug 03 08:27 PM
Poll Claire	General Counsel	Aug 02 '23	Sale	2.59	12,944	33,564	1,955,839	Aug 03 08:30 PM
ZACCARDELLI DAVID	President and CEO	Aug 01 '23	Sale	2.68	105,944	283,824	16,781,392	Aug 03 08:29 PM
Hahn Mark W	Chief Financial Officer	Aug 01 '23	Sale	2.68	105,944	283,824	15,870,840	Aug 03 08:31 PM
Rickard Kathleen A.	Chief Medical Officer	Aug 01 '23	Sale	2.68	19,736	52,873	2,966,400	Aug 03 08:27 PM
Poll Claire	General Counsel	Aug 01 '23	Sale	2.68	18,608	49,851	1,968,783	Aug 03 08:30 PM
Gupta Rishi	Director	May 15 '23	Sale	20.08	359,713	7,222,484	3,777,778	May 15 06:06 PM
ORBIMED ADVISORS LLC	Director	May 15 '23	Sale	20.08	359,713	7,222,484	3,777,778	May 15 06:07 PM
ORBIMED ADVISORS LLC	Director	May 12 '23	Sale	21.64	43,200	934,848	4,137,491	May 15 06:07 PM
Gupta Rishi	Director	May 12 '23	Sale	21.64	43,200	934,848	4,137,491	May 15 06:06 PM
Gupta Rishi	Director	May 11 '23	Sale	22.26	80,000	1,780,800	4,180,691	May 15 06:06 PM
ORBIMED ADVISORS LLC	Director	May 11 '23	Sale	22.26	80,000	1,780,800	4,180,691	May 15 06:07 PM

Open in Screener

MORF

Morphic Holding Inc

May 08 • 04:00PM ET

29.33

Dollar change -0.79
Percentage change -2.62	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

MORF Morphic Holding Inc daily Stock Chart

Held by: VTI IWM VXF IWO IBB SCHA LABU VTWO VHT ITOT

Index	RUT	P/E	-	EPS (ttm)	-3.38	Insider Own	22.64%	Shs Outstand	49.75M	Perf Week	4.86%
Market Cap	1.47B	Forward P/E	-	EPS next Y	-4.31	Insider Trans	-0.27%	Shs Float	38.75M	Perf Month	-4.68%
Income	-161.25M	PEG	-	EPS next Q	-0.97	Inst Own	88.75%	Short Float	16.14%	Perf Quarter	-20.34%
Sales	0.00M	P/S	-	EPS this Y	-9.58%	Inst Trans	-1.45%	Short Ratio	14.27	Perf Half Y	38.55%
Book/sh	13.25	P/B	2.21	EPS next Y	-9.68%	ROA	-28.67%	Short Interest	6.25M	Perf Year	-46.50%
Cash/sh	13.15	P/C	2.23	EPS next 5Y	-	ROE	-29.59%	52W Range	19.34 - 63.08	Perf YTD	1.56%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-35.64%	ROI	-24.25%	52W High	-53.51%	Beta	1.48
Dividend TTM	-	Quick Ratio	38.17	Sales past 5Y	134.56%	Gross Margin	-109.40%	52W Low	51.62%	ATR (14)	1.33
Dividend Ex-Date	-	Current Ratio	38.17	EPS Y/Y TTM	-109.60%	Oper. Margin	0.00%	RSI (14)	47.70	Volatility	3.51% 4.38%
Employees	121	Debt/Eq	0.00	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	1.40	Target Price	56.00
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	-0.54%	Payout	-	Rel Volume	0.76	Prev Close	30.12
Sales Surprise	-	EPS Surprise	3.70%	Sales Q/Q	-100.00%	Earnings	Apr 25 BMO	Avg Volume	438.15K	Price	29.33
SMA20	2.38%	SMA50	-8.82%	SMA200	-14.17%	Trades		Volume	332,870	Change	-2.62%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-08-23	Initiated	Citigroup	Buy	$46
Sep-25-23	Reiterated	Stifel	Hold	$61 → $33
Sep-25-23	Downgrade	BTIG Research	Buy → Neutral
Aug-09-23	Downgrade	Stifel	Buy → Hold	$69 → $61
Sep-07-22	Initiated	Stifel	Buy	$44
Jul-20-22	Initiated	SVB Leerink	Outperform	$45
Mar-31-22	Initiated	Canaccord Genuity	Buy	$68
Feb-11-22	Initiated	BTIG Research	Buy	$64
Dec-08-21	Initiated	Wells Fargo	Overweight	$81
Oct-26-20	Initiated	RBC Capital Mkts	Outperform	$35
Jul-22-19	Initiated	Wells Fargo	Outperform
Jul-22-19	Initiated	Jefferies	Buy
Jul-22-19	Initiated	Cowen	Outperform
Jul-22-19	Initiated	BMO Capital Markets	Outperform	$30

Show Previous Ratings

Apr-25-24 01:53PM	MORF Stock Earnings: Morphic Holding Beats EPS for Q1 2024 (InvestorPlace)
08:37AM	Morphic Holding Inc (MORF) Q1 2024 Earnings: A Detailed Review (GuruFocus.com)
07:00AM	Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024 (GlobeNewswire)
Apr-24-24 12:00PM	What Makes Morphic (MORF) a New Buy Stock (Zacks)
Mar-20-24 01:57PM	MORF Investor Notice: Abraham, Fruchter & Twersky, LLP Investigating Claims on Behalf of Investors of Morphic Holding, Inc. (NASDAQ:MORF) (GlobeNewswire)
08:00AM	Loading…
Mar-19-24 08:00AM	Morphic Appoints Dr. Simon Cooper as Chief Medical Officer (GlobeNewswire)
Mar-05-24 04:05PM	Morphic to Participate in March Investor Conferences (GlobeNewswire)
Feb-26-24 09:55AM	Wall Street Analysts See a 56.18% Upside in Morphic Holding, Inc. (MORF): Can the Stock Really Move This High? (Zacks)
Feb-22-24 07:00AM	Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023 (GlobeNewswire)
Feb-08-24 09:55AM	Wall Street Analysts Think Morphic Holding, Inc. (MORF) Could Surge 57.22%: Read This Before Placing a Bet (Zacks) +5.13%
Jan-18-24 01:04AM	Morphic Holding Inc CEO Praveen Tipirneni Sells 13,923 Shares (GuruFocus.com)
Jan-05-24 09:55AM	Wall Street Analysts Believe Morphic Holding, Inc. (MORF) Could Rally 110.28%: Here's is How to Trade (Zacks)
Jan-03-24 04:05PM	Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -5.57%
Dec-20-23 09:55AM	Does Morphic Holding, Inc. (MORF) Have the Potential to Rally 92.88% as Wall Street Analysts Expect? (Zacks) -5.01%
Dec-01-23 03:59PM	Robbins LLP Reminds MORF Investors that it is Investigating Morphic Holdings, Inc. on Behalf of Investors (Business Wire)
09:55AM	Loading…
09:55AM	Wall Street Analysts See a 150.17% Upside in Morphic Holding, Inc. (MORF): Can the Stock Really Move This High? (Zacks)
Nov-15-23 09:55AM	Wall Street Analysts Think Morphic Holding, Inc. (MORF) Could Surge 160.84%: Read This Before Placing a Bet (Zacks)
Nov-10-23 08:00AM	Morphic to Present at November Investor Conferences (GlobeNewswire)
Nov-09-23 12:00PM	Morphic Holding, Inc. (MORF) Moves to Buy: Rationale Behind the Upgrade (Zacks) -6.27%
Nov-06-23 04:24PM	Morphic Corporation: Company Investigated by the Portnoy Law Firm (GlobeNewswire) -6.20%
Nov-03-23 08:46AM	Morphic Holding Inc (MORF) Reports Q3 2023 Loss of $36.2 Million, Ends Quarter with $725. ... (GuruFocus.com) +8.20%
07:00AM	Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023 (GlobeNewswire)
Oct-09-23 08:00AM	Morphic Therapeutic to Host Webcast to Present EMERALD-1 Full Data Set (GlobeNewswire)
Sep-28-23 06:27AM	The Petri Dish: Ginkgo, Pfizer sign $331M deal; Leqembi OK'd in Japan (American City Business Journals)
Sep-26-23 04:10PM	Morphic Holdings Announces CEO Dr. Praveen Tipirneni to Take Temporary Medical Leave of Absence (GlobeNewswire) -7.82%
Sep-25-23 04:08PM	The Surprise That Prompted Morphic Therapeutic To Dump 55% Over Two Days (Investor's Business Daily) -36.91%
12:58PM	Morphic Therapeutic stock nosedives on disappointing trial data (American City Business Journals)
Sep-22-23 05:30PM	Morphic to Present Positive EMERALD-1 Phase 2a Data for MORF-057 in Patients with Moderate to Severe Ulcerative Colitis in Abstract for UEGW 2023 (GlobeNewswire) -28.64%
Sep-09-23 01:01PM	Morphic Holding Inc CFO and COO Marc Schegerin Sells 20,000 Shares (GuruFocus.com)
Aug-29-23 08:00AM	Morphic Announces Participation in 2023 Wells Fargo Healthcare Conference (GlobeNewswire)
04:05PM	Loading…
Aug-09-23 04:05PM	Morphic to Present at the Canaccord Genuity 43rd Annual Growth Conference (GlobeNewswire) -6.63%
Aug-07-23 06:24AM	Morphic Holding, Inc.'s (NASDAQ:MORF) large institutional owners must be happy as stock continues to impress, up 4.4% over the past week (Simply Wall St.)
Aug-03-23 08:55AM	Morphic Holding, Inc. (MORF) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
07:05AM	Morphic Announces Corporate Highlights and Financial Results for the Second Quarter 2023 (GlobeNewswire)
Jun-08-23 03:22PM	3 Stocks That Could Skyrocket by This Time Next Summer (InvestorPlace)
Jun-06-23 04:05PM	Morphic to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-26-23 03:31PM	Here's Why We're Not At All Concerned With Morphic Holding's (NASDAQ:MORF) Cash Burn Situation (Simply Wall St.)
May-22-23 05:23PM	Inside Scoop: 10 Mid-Cap Stocks with Recent Insider Purchases (Insider Monkey)
May-12-23 08:30AM	Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
May-11-23 08:00AM	Morphic Presents New Biomarker Data at DDW 2023 Supporting MORF-057 Program in Ulcerative Colitis (GlobeNewswire)
May-07-23 07:40PM	Insiders Pour Millions Into These 2 Strong Buy Stocks Heres Why You Might Want to Steer Toward Them Too (TipRanks)
May-06-23 08:13AM	Morphic Holding Founder Acquires 16% More Stock \ (Simply Wall St.)
May-05-23 10:30AM	Morphic Therapeutic Announces Closing of Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares (GlobeNewswire)
09:23AM	Q1 2023 Schrodinger Inc Earnings Call (Thomson Reuters StreetEvents)
May-03-23 12:13AM	Morphic Therapeutic Announces Pricing of $240.0 Million Public Offering (GlobeNewswire) +5.57%
May-02-23 04:02PM	Morphic Therapeutic Announces Proposed Public Offering (GlobeNewswire)
Apr-30-23 08:10AM	What Does The Future Hold For Morphic Holding, Inc. (NASDAQ:MORF)? These Analysts Have Been Cutting Their Estimates (Simply Wall St.)
Apr-29-23 08:25AM	3 Biotech Buyout Targets to Watch (Motley Fool)
Apr-27-23 06:10AM	The Zacks Analyst Blog Highlights Biogen, Incyte, Morphic Therapeutic and bluebird bio (Zacks)
Apr-26-23 07:06AM	Biotech Stock Roundup: BIIB's Q1 Results, ARWR Up on Data, INCY & BLUE Offer Updates (Zacks)
Apr-25-23 11:54AM	Morphic Therapeutic's Ulcerative Colitis Candidate Shows Clinically Meaningful Improvements Across Measures, Stock Soars (Benzinga) +7.28%
08:15AM	Morphic Holding, Inc. (MORF) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
07:00AM	Morphic Reports Positive Topline Results of the EMERALD-1 UC Main Cohort; Orally Administered MORF-057 Achieves Primary Endpoint and Demonstrates Clinically Meaningful Improvements Across Secondary and Exploratory Measures (GlobeNewswire)
06:59AM	Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2023 (GlobeNewswire)
Apr-24-23 04:01PM	Morphic Therapeutic to Host EMERALD-1 Topline Results Call on April 25, 2023 (GlobeNewswire)
Apr-18-23 10:56AM	Morphic Holding (NASDAQ:MORF) delivers shareholders strong 41% CAGR over 3 years, surging 20% in the last week alone (Simply Wall St.)
04:20AM	Morphic Holding, Inc. (MORF) Moves 22.5% Higher: Will This Strength Last? (Zacks)
Apr-09-23 01:19PM	7 Biotech Stocks to Buy for 100% Returns (InvestorPlace)
Mar-18-23 08:29AM	Some Analysts Just Cut Their Morphic Holding, Inc. (NASDAQ:MORF) Estimates (Simply Wall St.)
Mar-03-23 09:05AM	Morphic to Present at TD Cowen 43rd Annual Health Care Conference (GlobeNewswire)
Feb-24-23 05:26AM	Morphic Holding Full Year 2022 Earnings: Beats Expectations (Simply Wall St.)
Feb-23-23 08:00AM	Morphic Announces Corporate Highlights and Financial Results for the Full Year 2022 (GlobeNewswire)
Feb-15-23 09:04AM	Revenue Downgrade: Here's What Analysts Forecast For Morphic Holding, Inc. (NASDAQ:MORF) (Simply Wall St.)
Feb-14-23 08:00AM	Morphic to Present at SVB Leerink Global Healthcare Conference (GlobeNewswire) +5.49%
Jan-26-23 05:54AM	The Petri Dish: Morphic, J&J part ways; FDA committee to review another Biogen drug (American City Business Journals)
Jan-13-23 07:26AM	Morphic Holding, Inc. (MORF) Surges 18.7%: Is This an Indication of Further Gains? (Zacks)
Jan-05-23 09:09AM	Morphic to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-15-22 06:48AM	Here's Why We're Not Too Worried About Morphic Holding's (NASDAQ:MORF) Cash Burn Situation (Simply Wall St.)
Nov-22-22 08:00AM	Morphic Announces Initiation of EMERALD-2 Phase 2b Clinical Trial of MORF-057 in Patients with Moderate-to-Severe Ulcerative Colitis (GlobeNewswire)
Nov-09-22 08:00AM	Morphic Announces Participation in 2022 Jefferies London Healthcare Conference (GlobeNewswire)
Nov-04-22 06:29AM	Industry Analysts Just Made An Upgrade To Their Morphic Holding, Inc. (NASDAQ:MORF) Revenue Forecasts (Simply Wall St.)
Nov-02-22 09:15AM	Morphic Holding, Inc. (MORF) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
08:00AM	Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2022 (GlobeNewswire)
Oct-28-22 12:07PM	Vertex (VRTX) Beats on Q3 Earnings, Ups 2022 Sales Guidance (Zacks) +7.22%
Oct-27-22 12:26PM	BioMarin (BMRN) Q3 Earnings Beat, Sales Miss, Ups Voxzogo View (Zacks)
Oct-25-22 04:05PM	Morphic Presents New Positive MORF-057 Phase 1 Data at American College of Gastroenterology Annual Meeting 2022 (GlobeNewswire) +9.13%
01:59PM	Biogen (BIIB) Beats on Q3 Earnings & Sales, Raises 2022 Outlook (Zacks)
Oct-24-22 08:00AM	Morphic Announces Complete Enrollment of EMERALD-1 Main Cohort Ahead of Projections (GlobeNewswire)
Oct-20-22 01:19PM	Moderna (MRNA) Gets CHMP Nod for Omicron BA.4, BA.5 Booster Jab (Zacks)
Oct-10-22 08:00AM	Morphic Presents New Positive MORF-057 Phase 1 Data at UEG Week 2022 (GlobeNewswire)
Sep-30-22 01:20PM	Sarepta (SRPT) Seeks FDA Nod for DMD Gene Therapy Candidate (Zacks)
10:22AM	Those who invested in Morphic Holding (NASDAQ:MORF) three years ago are up 66% (Simply Wall St.)
Sep-29-22 12:00PM	EMA Accepts Moderna's (MRNA) Filing for Omicron BA.4, BA.5 Booster (Zacks)
10:15AM	Morphic Holding, Inc. (MORF) Moves 7.3% Higher: Will This Strength Last? (Zacks)
Sep-28-22 12:00PM	Morphic Congratulates Timothy A. Springer, PhD as 2022 Albert Lasker Basic Medical Research Award Honoree (GlobeNewswire) +7.31%
Sep-27-22 12:46PM	Pfizer (PFE) Seeks FDA Approval for Omicron Booster in Kids (Zacks) +6.22%
Sep-26-22 12:39PM	Valneva (VALN) Stock Down 66% in the Past 6 Months: Here's Why (Zacks)
11:17AM	AstraZeneca's (AZN) Ultomiris Gets EC Nod for New Indication (Zacks)
Sep-23-22 11:14AM	Merck's (MRK) Stock Up on Januvia Patent Win Against Viatris (Zacks)
11:02AM	Spero (SPRO) Skyrockets 168% on Licensing Deal With GSK (Zacks)
Sep-22-22 01:28PM	Eli Lilly (LLY) Gets FDA Nod for RET Inhibitor in Solid Tumors (Zacks)
Sep-21-22 11:44AM	AstraZeneca (AZN) Gets EU Nod for Evusheld to Treat COVID (Zacks)
07:00AM	Morphic Celebrates Foundational Integrin Research Published in Cell (GlobeNewswire)
Sep-20-22 12:10PM	AbbVie (ABBV) Gets CHMP Nod for Skyrizi in a Third Indication (Zacks)
Sep-19-22 12:28PM	Sanofi (SNY) Gets CHMP Nod for Enjaymo in Hemolytic Anemia (Zacks)
12:21PM	Merck's (MRK) Pneumococcal Jab Gets CHMP Endorsement for Kids (Zacks)
Sep-16-22 11:42AM	Eloxx (ELOX) Down After Cystic Fibrosis Study Fails to Meet Goal (Zacks)
Sep-15-22 12:15PM	J&J (JNJ) Announces $5B Stock Repurchase Program, Stock Up (Zacks)
11:54AM	Pfizer (PFE) Starts Late-Stage Study on Influenza Vaccine (Zacks)
Sep-14-22 01:33PM	Key Factors Driving Merck's (MRK) Outperformance This Year (Zacks)

Morphic Holding, Inc., operates as a biopharmaceutical company, which researches and develops oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rogers Bruce	PRESIDENT	Mar 27 '24	Option Exercise	4.32	7,400	31,932	149,883	Mar 28 07:00 PM
Tipirneni Praveen P.	CEO	Jan 16 '24	Sale	27.49	13,923	382,753	42,013	Jan 17 07:04 PM
Rogers Bruce	President	Jan 16 '24	Sale	27.49	6,314	173,576	142,036	Jan 17 07:02 PM
SCHEGERIN MARC	CFO and COO	Jan 16 '24	Sale	27.49	6,041	166,071	37,460	Jan 17 07:03 PM
Farrell Robert E Jr	SVP Finance and CAO	Jan 16 '24	Sale	27.49	5,089	139,900	34,992	Jan 17 07:01 PM
DeVaul William	General Counsel and Secretary	Jan 16 '24	Sale	27.49	4,509	123,956	23,029	Jan 17 07:00 PM
DeVaul William	General Counsel and Secretary	Jan 14 '24	Option Exercise	0.00	3,250	0	27,538	Jan 17 07:00 PM
Farrell Robert E Jr	SVP Finance and CAO	Jan 14 '24	Option Exercise	0.00	3,470	0	40,081	Jan 17 07:01 PM
Rogers Bruce	President	Jan 14 '24	Option Exercise	0.00	5,070	0	148,350	Jan 17 07:02 PM
SCHEGERIN MARC	CFO and COO	Jan 14 '24	Option Exercise	0.00	4,690	0	43,501	Jan 17 07:03 PM
Tipirneni Praveen P.	CEO	Jan 14 '24	Option Exercise	0.00	12,500	0	55,936	Jan 17 07:04 PM
Tipirneni Praveen P.	CEO	Jan 13 '24	Option Exercise	0.00	29,500	0	43,436	Jan 17 07:04 PM
SCHEGERIN MARC	CFO and COO	Jan 13 '24	Option Exercise	0.00	14,675	0	38,811	Jan 17 07:03 PM
Rogers Bruce	President	Jan 13 '24	Option Exercise	0.00	15,225	0	143,280	Jan 17 07:02 PM
Farrell Robert E Jr	SVP Finance and CAO	Jan 13 '24	Option Exercise	0.00	12,675	0	36,611	Jan 17 07:01 PM
DeVaul William	General Counsel and Secretary	Jan 13 '24	Option Exercise	0.00	10,950	0	24,288	Jan 17 07:00 PM
SLATTERY JOSEPH P	Director	Nov 13 '23	Buy	20.60	2,400	49,436	9,066	Nov 14 07:04 PM
Edwards Martin	Director	Nov 13 '23	Buy	20.54	2,376	48,803	2,376	Nov 15 07:00 PM
SCHEGERIN MARC	CFO and COO	Sep 07 '23	Option Exercise	15.00	20,000	300,000	44,136	Sep 08 07:00 PM
SCHEGERIN MARC	CFO and COO	Sep 07 '23	Sale	54.34	20,000	1,086,849	24,136	Sep 08 07:00 PM
Tipirneni Praveen P.	President and CEO	Aug 01 '23	Option Exercise	4.32	3,597	15,539	17,533	Aug 03 06:58 PM
Tipirneni Praveen P.	President and CEO	Aug 01 '23	Sale	57.04	3,597	205,187	13,936	Aug 03 06:58 PM
Tipirneni Praveen P.	President and CEO	Jul 03 '23	Option Exercise	4.32	3,597	15,539	17,533	Jul 06 07:02 PM
Tipirneni Praveen P.	President and CEO	Jul 03 '23	Sale	57.04	3,597	205,178	13,936	Jul 06 07:02 PM
Tipirneni Praveen P.	President and CEO	Jun 12 '23	Option Exercise	4.32	840	3,629	14,776	Jun 14 07:04 PM
Tipirneni Praveen P.	President and CEO	Jun 12 '23	Sale	63.01	840	52,929	13,936	Jun 14 07:04 PM
DeVaul William	General Counsel and Secretary	Jun 07 '23	Sale	60.05	7,756	465,742	13,338	Jun 09 07:00 PM
Tipirneni Praveen P.	President and CEO	Jun 01 '23	Option Exercise	4.32	3,597	15,539	17,533	Jun 02 07:01 PM
Tipirneni Praveen P.	President and CEO	Jun 01 '23	Sale	57.14	3,597	205,519	13,936	Jun 02 07:01 PM
DeVaul William	General Counsel and Secretary	May 24 '23	Sale	60.00	100	6,000	21,094	May 25 08:44 PM
Farrell Robert E Jr	SVP Finance and CAO	May 23 '23	Option Exercise	4.32	10,000	43,200	33,708	May 25 08:45 PM
Farrell Robert E Jr	SVP Finance and CAO	May 23 '23	Sale	60.00	10,000	600,000	23,708	May 25 08:45 PM
DeVaul William	General Counsel and Secretary	May 23 '23	Sale	60.03	3,802	228,236	21,194	May 25 08:44 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

VRNA

Verona Pharma Plc ADR

MORF

Morphic Holding Inc

Upgrade your FINVIZ experience